Victoria Wang

9.7k total citations
44 papers, 805 citations indexed

About

Victoria Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Victoria Wang has authored 44 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Victoria Wang's work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Victoria Wang is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Victoria Wang collaborates with scholars based in United States, Canada and Ireland. Victoria Wang's co-authors include Dean Tantin, Phillip A. Sharp, Caroline Schild‐Poulter, Robert J.G. Haché, Robert C. Cooksey, Arvind Shakya, James E. Cox, Donald A. McClain, Vinod Vathipadiekal and Levi Waldron and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Victoria Wang

41 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victoria Wang United States	12	379	242	155	129	129	44	805
Bálint Nagy Hungary	20	548 1.4×	208 0.9×	120 0.8×	143 1.1×	140 1.1×	52	1.1k
Massimo Masiero Italy	16	405 1.1×	157 0.6×	192 1.2×	70 0.5×	89 0.7×	23	806
Stefan Wilop Germany	21	631 1.7×	237 1.0×	130 0.8×	62 0.5×	100 0.8×	48	1.1k
Ágnes F. Semsei Hungary	19	316 0.8×	220 0.9×	122 0.8×	43 0.3×	87 0.7×	38	788
Steven M. Bair United States	9	415 1.1×	171 0.7×	96 0.6×	76 0.6×	49 0.4×	22	671
Mingguo Huang Japan	20	433 1.1×	212 0.9×	254 1.6×	65 0.5×	284 2.2×	51	1.1k
Akihiro Ohmoto Japan	14	158 0.4×	418 1.7×	130 0.8×	114 0.9×	99 0.8×	75	706
Marco Johannes Battista Germany	18	245 0.6×	426 1.8×	205 1.3×	47 0.4×	154 1.2×	76	998
Shinji Itoyama Japan	20	353 0.9×	478 2.0×	173 1.1×	337 2.6×	192 1.5×	64	1.3k
Sally Baron‐Hay Australia	14	237 0.6×	388 1.6×	113 0.7×	122 0.9×	70 0.5×	48	775

Countries citing papers authored by Victoria Wang

Since Specialization

Citations

This map shows the geographic impact of Victoria Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Wang more than expected).

Fields of papers citing papers by Victoria Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Wang. The network helps show where Victoria Wang may publish in the future.

Co-authorship network of co-authors of Victoria Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Wang. A scholar is included among the top collaborators of Victoria Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Wang. Victoria Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Victoria, Kevin M. Elias, Ross S. Berkowitz, & Neil S. Horowitz. (2024). Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors. Hematology/Oncology Clinics of North America. 38(6). 1277–1286. 2 indexed citations

Salama, April K.S., Victoria Wang, Erin Macrae, et al.. (2024). Dabrafenib and trametinib in patients with tumors with BRAF V600E/k mutations: Updated results from NCI-MATCH arm H.. Journal of Clinical Oncology. 42(16_suppl). 3110–3110. 1 indexed citations

Gettinger, Scott, Karen L. Reckamp, Jeffrey A. Moscow, et al.. (2024). Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. JCO Precision Oncology. 8(8). e2300725–e2300725. 2 indexed citations

Wang, Victoria, et al.. (2024). Concurrent laparoscopic hysterectomy and bariatric surgery for early-stage endometrial cancer and endometrial intraepithelial neoplasia: Lessons learned from an interdisciplinary prospective feasibility trial. Gynecologic Oncology. 190. S268–S269. 1 indexed citations

Wang, Victoria, et al.. (2024). The effects of Asian American Pacific Islander (AAPI) data inequities in gynecologic oncology. Gynecologic Oncology. 189. 64–67.

Valentim, Carolina C. S., Qinqin Zhang, Weilin Song, et al.. (2024). Deep learning-based algorithm for the detection of idiopathic full thickness macular holes in spectral domain optical coherence tomography. International Journal of Retina and Vitreous. 10(1). 9–9. 3 indexed citations

Osann, Kathryn, Lari Wenzel, Chelsea McKinney, et al.. (2023). Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors. Gynecologic Oncology. 171. 151–158. 11 indexed citations

Wang, Victoria, Kim Brustoski, Sripriya Sarangapani, et al.. (2020). Risk Factors for Proliferative Diabetic Retinopathy and Diabetic Macular Edema in the South Indian Population. Investigative Ophthalmology & Visual Science. 61(7). 4842–4842. 1 indexed citations

Lawlor, Matthew, Polydoros Ν. Kampaktsis, Victoria Wang, et al.. (2020). TCT CONNECT-497 Incidence and Predictors of Cardiogenic Shock Following Tricuspid Valve Repair or Replacement. Journal of the American College of Cardiology. 76(17). B212–B212. 1 indexed citations

10.

Zeidan, Amer M., Victoria Wang, Jerald P. Radich, et al.. (2020). Blast MRD CML 1 Trial: Blockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease (MRD) in Chronic Myeloid Leukemia (CML)- a Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease: A Trial of the ECOG-ACRIN Cancer Research Group (EA9171). Blood. 136(Supplement 1). 1–1. 4 indexed citations

11.

Greenlee, Tyler E., Victoria Wang, Grant L. Hom, et al.. (2020). Consequences of Lapses in Treatment with Vascular Endothelial Growth Factor Inhibitors in Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 61(7). 4202–4202. 1 indexed citations

12.

Hoaglin, David C., David D. McManus, Victoria Wang, et al.. (2018). Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis. PLoS ONE. 13(5). e0197583–e0197583. 60 indexed citations

13.

Vathipadiekal, Vinod, Victoria Wang, Wei Wei, et al.. (2015). Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array. Clinical Cancer Research. 21(21). 4960–4969. 69 indexed citations

14.

Magbanua, Mark Jesus M., Michael J. Pugia, Jin Sun Lee, et al.. (2015). A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay. PLoS ONE. 10(10). e0141166–e0141166. 18 indexed citations

15.

Willis, Scooter, Pradip De, Nandini Dey, et al.. (2015). Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs. Meta Gene. 4. 129–141. 16 indexed citations

16.

Uldrick, Thomas S., Mark N. Polizzotto, Karen Aleman, et al.. (2014). Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. Blood. 124(24). 3544–3552. 80 indexed citations

17.

Loughran, Thomas P., Victoria Wang, Dapeng Zhang, et al.. (2014). Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998). Leukemia. 29(4). 886–894. 78 indexed citations

18.

Shakya, Arvind, Robert C. Cooksey, James E. Cox, et al.. (2009). Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity. Nature Cell Biology. 11(3). 320–327. 80 indexed citations

19.

Newton, Philip M., Victoria Wang, Melisa J. Wallace, et al.. (2008). A Blocker of N- and T-type Voltage-Gated Calcium Channels Attenuates Ethanol-Induced Intoxication, Place Preference, Self-Administration, and Reinstatement. Journal of Neuroscience. 28(45). 11712–11719. 29 indexed citations

20.

Tantin, Dean, Caroline Schild‐Poulter, Victoria Wang, Robert J.G. Haché, & Phillip A. Sharp. (2005). The Octamer Binding Transcription Factor Oct-1 Is a Stress Sensor. Cancer Research. 65(23). 10750–10758. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact